KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) Return on Assets (2016 - 2025)

Rigel Pharmaceuticals has reported Return on Assets over the past 15 years, most recently at 0.01% for Q4 2025.

  • For Q4 2025, Return on Assets rose 1.0% year-over-year to 0.01%; the TTM value through Dec 2025 reached 0.01%, up 1.0%, while the annual FY2025 figure was 0.01%, 1.0% up from the prior year.
  • Return on Assets for Q4 2025 was 0.01% at Rigel Pharmaceuticals, up from 0.01% in the prior quarter.
  • Over five years, Return on Assets peaked at 0.01% in Q4 2025 and troughed at 0.01% in Q3 2022.
  • A 5-year average of 0.0% and a median of 0.0% in 2024 define the central range for Return on Assets.
  • Biggest five-year swings in Return on Assets: fell -1bps in 2022 and later grew 1bps in 2025.
  • Year by year, Return on Assets stood at 0.0% in 2021, then plummeted by -363bps to 0.0% in 2022, then soared by 54bps to 0.0% in 2023, then soared by 153bps to 0.0% in 2024, then soared by 742bps to 0.01% in 2025.
  • Business Quant data shows Return on Assets for RIGL at 0.01% in Q4 2025, 0.01% in Q3 2025, and 0.01% in Q2 2025.